Aspiro Pharma Limited — Vancomycin Exporter Profile
Indian Pharmaceutical Exporter · #6 for Vancomycin · $5.4M export value · DGFT Verified
Aspiro Pharma Limited is the #6 Indian exporter of Vancomycin with $5.4M in export value and 149 verified shipments. Aspiro Pharma Limited holds a 5.8% market share in Vancomycin exports across 19 countries. The company exports 3 pharmaceutical products worth $8.0M across 3 therapeutic categories.
Aspiro Pharma Limited — Vancomycin Export Profile: Buyers & Destinations
Where Does Aspiro Pharma Limited Export Vancomycin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| SAUDI ARABIA | $1.3M | 30 | 36.5% |
| PHILIPPINES | $522.3K | 29 | 15.0% |
| COSTA RICA | $339.4K | 9 | 9.8% |
| CHILE | $279.2K | 13 | 8.0% |
| UNITED STATES | $223.4K | 5 | 6.4% |
| COLOMBIA | $208.3K | 9 | 6.0% |
| THAILAND | $109.7K | 9 | 3.2% |
| VIETNAM | $100.0K | 2 | 2.9% |
| VIETNAM, DEMOCRATIC REP. OF | $83.7K | 3 | 2.4% |
| VIETNAM DEMOCRATIC REP. OF | $44.3K | 1 | 1.3% |
Aspiro Pharma Limited exports Vancomycin to 23 countries. The largest destination is SAUDI ARABIA accounting for 36.5% of Aspiro Pharma Limited's Vancomycin shipments, followed by PHILIPPINES (15.0%) and COSTA RICA (9.8%). These destinations reflect Aspiro Pharma Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Vancomycin from Aspiro Pharma Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO THE ORDER OF | PHILIPPINES | $1.5M | 57 |
| SAUDI AMAROX FOR INDUSTRY | SAUDI ARABIA | $497.3K | 11 |
| TO THE ORDER OF., | THAILAND | $369.6K | 14 |
| TO THE ORDER | THAILAND | $135.0K | 10 |
| SEVEN PHARMA CHILE S P A | CHILE | $90.0K | 4 |
| SEVEN PHARMA COLOMBIA SAS | COLOMBIA | $83.2K | 3 |
| SAUDI AMAROX FOR INDUSTRY COMPANY | SAUDI ARABIA | $78.2K | 2 |
| CAMBER PHARMACEUTICALS, INC. | PHILIPPINES | $75.2K | 4 |
| M S TO THE ORDER SAUDI AMAROX FOR INDUSTRY | SAUDI ARABIA | $74.4K | 2 |
| HOANG DUC PHARMACEUTICAL & MEDICAL | VIETNAM | $50.0K | 1 |
Aspiro Pharma Limited supplies Vancomycin to 38 buyers globally. The largest buyer is TO THE ORDER OF (PHILIPPINES), followed by SAUDI AMAROX FOR INDUSTRY (SAUDI ARABIA) and TO THE ORDER OF., (THAILAND). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Vancomycin Export Value and How Much Does Aspiro Pharma Limited Contribute?
India exported $58.7M worth of Vancomycin through 3,071 shipments from 318 suppliers to 140 countries, serving 743 buyers globally. Aspiro Pharma Limited contributes $5.4M to this total, accounting for 5.8% of India's Vancomycin exports. Aspiro Pharma Limited ships Vancomycin to 23 countries through 38 buyers.
What Is the Average Shipment Value for Aspiro Pharma Limited's Vancomycin Exports?
Aspiro Pharma Limited's average Vancomycin shipment value is $36.1K per consignment, based on 149 shipments totaling $5.4M. The largest destination is SAUDI ARABIA (36.5% of Aspiro Pharma Limited's Vancomycin exports).
How Does Aspiro Pharma Limited Compare to Other Indian Vancomycin Exporters?
Aspiro Pharma Limited ranks #6 among 318 Indian Vancomycin exporters with a 5.8% market share. The top 3 exporters are MYLAN LABORATORIES LIMITED ($15.9M), STRIDES PHARMA SCIENCE LIMITED ($11.0M), GLAND PHARMA LIMITED ($5.4M). Aspiro Pharma Limited processed 149 shipments to 19 destination countries.
What Vancomycin Formulations Does Aspiro Pharma Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| VANIN VANCOMYCIN INJECTION INJ | $345.4K | 8 |
| VANCOMYCIN INJECTION INJ (VANIN) | $218.8K | 5 |
| VANIN VANCOMYCIN INJECTION | $184.5K | 5 |
| VANCOMYCIN INJECTION | $167.1K | 7 |
| VANCONEX VANCOMYCIN INJECTION INJ | $144.3K | 3 |
| VANIN VANCOMYCIN INJECTION | $142.2K | 3 |
| VANCOMYCIN INJECTION INJ | $102.4K | 8 |
| VANCOMYCIN INJECTION 500MG INJ (11256 X | $100.0K | 2 |
| VANCOMYCIN INJECTION 500MG INJ (8755 X 1 | $100.0K | 2 |
| VANCOMYCIN INJECTION 500MG INJ (PACKS IN | $100.0K | 2 |
Aspiro Pharma Limited exports 82 distinct Vancomycin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is VANIN VANCOMYCIN INJECTION INJ with 8 shipments worth $345.4K.
How Does Aspiro Pharma Limited Compare to Nearest Vancomycin Exporters?
Exporters ranked immediately above and below #6 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | STRIDES PHARMA SCIENCE LIMITED | $11.0M | 220 | 11 | $50.0K |
| 3 | GLAND PHARMA LIMITED | $5.4M | 108 | 7 | $50.0K |
| 6 | ASPIRO PHARMA LIMITED ★ | $5.4M | 149 | 19 | $36.1K |
| 7 | GUFIC BIOSCIENCES LIMITED | $5.2M | 165 | 12 | $31.3K |
| 5 | GLAND PHARMA LTD | $3.0M | 59 | 7 | $50.0K |
Aspiro Pharma Limited ranks #6 among 318 Indian Vancomycin exporters. Average shipment value of $36.1K compared to the market average of $184.6K. The closest competitors by value are STRIDES PHARMA SCIENCE LIMITED and GLAND PHARMA LIMITED.
Which Indian Ports Ship Vancomycin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 406 | 13.2% |
| SAHAR AIR CARGO ACC (INBOM4) | 395 | 12.9% |
| NHAVA SHEVA SEA (INNSA1) | 221 | 7.2% |
| DELHI AIR | 135 | 4.4% |
| BANGALORE ACC (INBLR4) | 134 | 4.4% |
| BANGALORE AIR | 133 | 4.3% |
| BANGALORE ICD (INWFD6) | 119 | 3.9% |
| HYDERABAD ACC (INHYD4) | 116 | 3.8% |
Geopolitical & Trade Policy Impact on Aspiro Pharma Limited's Vancomycin Exports
The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Aspiro Pharma. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, causing increased freight costs and extended transit times. These logistical challenges can impact the timely delivery of pharmaceuticals, which is critical for maintaining supply chain integrity and meeting contractual obligations. (pharmaceuticalcommerce.com)
Conversely, the US-China trade tensions have opened avenues for Indian exporters to fill the gap left by Chinese suppliers. Aspiro Pharma can leverage this opportunity by strengthening its presence in the US market, especially given India's existing supply of 40% of the US's generic drug needs. (ibef.org) However, potential US tariffs on pharmaceutical imports necessitate a cautious approach, as they could affect pricing strategies and profit margins. (business-standard.com)
The recent India-European Union Free Trade Agreement (FTA) signed in January 2026 is another significant development. The FTA aims to eliminate tariffs on pharmaceuticals, potentially enhancing market access for Indian exporters. Aspiro Pharma should monitor the implementation of this agreement to capitalize on reduced trade barriers and expand its footprint in the European market. (en.wikipedia.org)
Aspiro Pharma Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is a cornerstone for success in pharmaceutical exports. India has made significant strides in this area, surpassing the US in the number of FDA-registered generic manufacturing sites, with 752 FDA-approved facilities as of 2024. (business-standard.com) For Aspiro Pharma, maintaining stringent quality control measures and adhering to Good Manufacturing Practices (GMP) are essential to ensure continued access to regulated markets.
The European Union's Falsified Medicines Directive (FMD) imposes additional requirements for traceability and verification of pharmaceutical products. Aspiro Pharma must ensure compliance with these regulations to prevent counterfeit medicines from entering the supply chain and to maintain trust with European partners.
About Aspiro Pharma Limited
Aspiro Pharma Limited exports 3 products worth $8.0M. Beyond Vancomycin, top products include Voriconazole, Ketorolac. View the complete Aspiro Pharma Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Vancomycin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Vancomycin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Aspiro Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 149 individual customs records matching Aspiro Pharma Limited exporting Vancomycin, covering 82 formulations to 23 countries via 38 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 140+ countries, 743+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Vancomycin Export Data from Aspiro Pharma Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Aspiro Pharma Limited's Vancomycin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Aspiro Pharma Limited
Full Company Profile →
3 products · $8.0M total trade · 3 categories
Vancomycin Stats
Company Overview
Top Products by Aspiro Pharma Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Aspiro Pharma Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Vancomycin. For current shipment-level data, contact TransData Nexus.